Search Results - "Kanki, Phyllis"

Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria by Meloni, Seema T, Agaba, Patricia, Chang, Charlotte A, Yiltok, Esther, Oguche, Stephen, Ejeliogu, Emeka, Agbaji, Oche, Okonkwo, Prosper, Kanki, Phyllis J

“…Introduction Adherence to antiretroviral therapy (ART) and retention in treatment programs are required for successful virologic suppression and treatment…”
Get full text

Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study by Oluwole, Esther O, Adeyemo, Titilope A, Osanyin, Gbemisola E, Odukoya, Oluwakemi O, Kanki, Phyllis J, Afolabi, Bosede B

“…In Nigeria, about 150000 babies are born annually with sickle cell disease (SCD), and this figure has been estimated to increase by 100% by the year 2050…”
Get full text

Antiretroviral therapy retention, adherence, and clinical outcomes among postpartum women with HIV in Nigeria by Young, Clara M, Chang, Charlotte A, Sagay, Atiene S, Imade, Godwin, Ogunsola, Olabanjo O, Okonkwo, Prosper, Kanki, Phyllis J

“…While research involving pregnant women with HIV has largely focused on the antepartum and intrapartum periods, few studies in Nigeria have examined the…”
Get full text

Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort by Kirby, James E, Riedel, Stefan, Dutta, Sanjucta, Arnaout, Ramy, Cheng, Annie, Ditelberg, Sarah, Hamel, Donald J, Chang, Charlotte A, Kanki, Phyllis J

“…To define the relationship of SARS-CoV-2 antigen, viral load determined by RT-qPCR, and viral culture detection. Presumptively, viral culture can provide a…”
Get more information

Acceptability of and Preferences for Long-Acting Injectable HIV PrEP and Other PrEP Modalities among Sexual Minority Men in Nigeria, Africa by Ogunbajo, Adedotun, Tsai, Alexander C., Kanki, Phyllis J., Mayer, Kenneth H.

“…Sexual minority men (SMM) in Nigeria have been disproportionately affected by HIV. Pre-exposure prophylaxis (PrEP) reduces risk for HIV acquisition among SMM…”
Get full text

Status of HIV-infected patients classified as lost to follow up from a large antiretroviral program in southwest Nigeria by Balogun, Mobolanle, Meloni, Seema Thakore, Igwilo, Ugonnaya Ugochinyere, Roberts, Alero, Okafor, Ifeoma, Sekoni, Adekemi, Ogunsola, Folasade, Kanki, Phyllis J, Akanmu, Sulaimon

“…Loss to follow-up (LTFU) is a term used to classify patients no longer being seen in a clinical care program, including HIV treatment programs. It is unclear…”
Get full text

Intersectional Stigma and HIV ContinuumOutcomes Among Sexual Minority Men in Sub-SaharanAfrica: A Conceptual Framework by Ogunbajo, Adedotun, Mayer, Kenneth H, Kanki, Phyllis J, Tsai, Alexander C

“…Sexual minority men (SMM)-which we define as cisgender and transgender men who are romantically attracted, sexually attracted, or both to other cisgender and…”
Get full text

Intersectional Stigma and HIV Continuum Outcomes Among Sexual Minority Men in Sub-Saharan Africa: A Conceptual Framework by Ogunbajo, Adedotun, Mayer, Kenneth H, Kanki, Phyllis J, Tsai, Alexander C

Get full text

Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron and Delta Variants of Concern Using Live-Virus Culture by Stanley, Sydney, Hamel, Donald J, Wolf, Ian D, Riedel, Stefan, Dutta, Sanjucta, Contreras, Elisa, Callahan, Cody J, Cheng, Annie, Arnaout, Ramy, Kirby, James E, Kanki, Phyllis J

Get full text

The HIV-2 proviral landscape is dominated by defective proviruses by Koofhethile, Catherine K, Gao, Ce, Chang, Charlotte, Lian, Xiaodong, Shapiro, Roger, Yu, Xu G, Lichterfeld, Mathias, Kanki, Phyllis J

“…Compared with HIV-1 infection, HIV-2 infection is associated with a slower progression to AIDS. Understanding the persistence of HIV-2 infection might inform…”
Get full text

Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria by Meloni, Seema T, Chang, Charlotte A, Eisen, Geoffrey, Jolayemi, Toyin, Banigbe, Bolanle, Okonkwo, Prosper I, Kanki, Phyllis J

“…While there has been a rapid global scale-up of antiretroviral therapy programs over the past decade, there are limited data on long-term outcomes from large…”
Get full text

The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation by Ogbenna, Ann Abiola, Meloni, Seema, Inzaule, Seth, Hamers, Raph L, Sigaloff, Kim, Osibogun, Akin, Adeyemo, Titilope Adenike, Okonkwo, Prosper, Samuels, Jay Osi, Kanki, Phyllis J, Rinke de Wit, Tobias F, Akanmu, Alani Sulaimon

“…HIV is a highly diverse virus with significant genetic variability which may confer biologic differences that could impact on treatment outcomes. We studied…”
Get full text

A Review of the Virological Efficacy of the 4 World Health Organization—Recommended Tenofovir-Containing Regimens for Initial HIV Therapy by Tang, Michele W., Kanki, Phyllis J., Shafer, Robert W.

“…We systematically reviewed studies of the virological efficacy of the 4 new tenofovir (TDF)-containing regimens recommended for initial antiretroviral (ARV)…”
Get full text

Continued Transmission of Zika Virus in Humans in West Africa, 1992-2016 by Herrera, Bobby Brooke, Chang, Charlotte A., Hamel, Donald J., Mboup, Souleymane, Ndiaye, Daouda, Imade, Godwin, Okpokwu, Jonathan, Agbaji, Oche, Bei, Amy K., Kanki, Phyllis J.

“…First identified in 1947 in Uganda, Zika virus (ZIKV) has remained largely unstudied until the recent outbreak in Latin America. This study aimed to measure…”
Get full text

SARS-CoV-2 live virus culture and sample freeze-thaw stability by Kanki, Phyllis J., Hamel, Donald J., Riedel, Stefan, Dutta, Sanjucta, Cheng, Annie, Chang, Charlotte A., Arnaout, Ramy, Kirby, James E.

“…•SARS-CoV-2 patient samples covered the range of cycle threshold values.•Split samples were cultured fresh and after storage at 80 °C for 7 or 17-18…”
Get full text

Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa by Herrera, Bobby Brooke, Tsai, Wen-Yang, Chang, Charlotte A, Hamel, Donald J, Wang, Wei-Kung, Lu, Yichen, Mboup, Souleymane, Kanki, Phyllis J

“…Recent studies on the role of T cells in Zika virus (ZIKV) infection have shown that T cell responses to Asian ZIKV infection are important for protection, and…”
Get full text

Arbovirus surveillance in pregnant women in north-central Nigeria, 2019-2022 by Ogwuche, Jerry, Chang, Charlotte Ajeong, Ige, Olukemi, Sagay, Atiene S, Chaplin, Beth, Kahansim, Makshwar L, Paul, Michael, Elujoba, Michael, Imade, Godwin, Kweashi, Georgenia, Dai, Yu-Ching, Hsieh, Szu-Chia, Wang, Wei-Kung, Hamel, Donald J, Kanki, Phyllis J

“…The adverse impact of Zika (ZIKV), dengue (DENV), and chikungunya (CHIKV) virus infection in pregnancy has been recognized in Latin America and Asia but is not…”
Get full text

Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in Nigeria by Rawizza, Holly E, Chaplin, Beth, Meloni, Seema T, Darin, Kristin M, Olaitan, Oluremi, Scarsi, Kimberly K, Onwuamah, Chika K, Audu, Rosemary A, Chebu, Philippe R, Imade, Godwin E, Okonkwo, Prosper, Kanki, Phyllis J

“…To date, antiretroviral therapy (ART) guidelines and programs in resource-limited settings (RLS) have focused on 1(st)- and 2(nd)-line (2 L) therapy. As…”
Get full text

Chikungunya virus antepartum transmission and abnormal infant outcomes in a cohort of pregnant women in Nigeria by Sagay, Atiene S, Hsieh, Szu-Chia, Dai, Yu-Ching, Chang, Charlotte Ajeong, Ogwuche, Jerry, Ige, Olukemi O, Kahansim, Makshwar L, Chaplin, Beth, Imade, Godwin, Elujoba, Michael, Paul, Michael, Hamel, Donald J, Furuya, Hideki, Khouri, Ricardo, Boaventura, Viviane Sampaio, de Moraes, Laíse, Kanki, Phyllis J, Wang, Wei-Kung

“…Chikungunya virus (CHIKV), a reemerging global public health concern, which causes acute febrile illness, rash, and arthralgia and may affect both mothers and…”
Get full text

Trained community volunteers improve tuberculosis knowledge and attitudes among adults in a periurban community in southwest Nigeria by Balogun, Mobolanle, Sekoni, Adekemi, Meloni, Seema Thakore, Odukoya, Oluwakemi, Onajole, Adebayo, Longe-Peters, Olukemi, Ogunsola, Folasade, Kanki, Phyllis J

“…Nigeria has the world's 10th largest tuberculosis (TB) burden. Targeted community-based interventions can potentially help reduce TB incidence. We designed an…”
Get full text